Insider Cluster (2 insiders) ·Filed Aug 13, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $2.8M total
Actionable Insight • Neutral

These sales are routine post-earnings liquidity events at a mega-cap pharma. No bearish read-through — the dollar value is negligible relative to market cap and the timing aligns with standard blackout-window openings. Monitor for any unexpected C-suite sales (CEO/CFO) which would carry more signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
MRK ▲ +6.63% at T+20d
NEUTRAL call ✓ call won +6.63% · α vs SPY +8.62% · entry $135.84 → $144.85
Next anchor: T+60d in 5w
Latest observation: T+33 +4.06% FF3 residual α
Entry anchored
Aug 13, 04:57 PM ET
via 1-min bar
T+1d
+0.10%
call +0.10% · α +0.57%
$135.97
settled 7w ago
T+5d
+12.30%
call +12.30% · α +13.67%
$152.55
settled 6w ago
T+20d
+6.63%
call +6.63% · α +8.62%
$144.85
settled 21d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Two Merck EVPs sold a combined $2.81M in open-market stock over the past week, following the company's Q2 earnings beat and raised sales guidance. The sales are small relative to Merck's $327.9B market cap (~0.0009%), making them routine portfolio adjustments rather than a bearish signal. The cluster occurs 9 days post-earnings, a common window for planned sales after blackout periods lift.

Key Financial Metrics

Direction
selling
Total Value
$7.3M
Insiders
2

Key Facts

  • EVP Richard DeLuca sold ~45,320 shares across four transactions totaling ~$5.94M (Aug 10-12).
  • EVP Chirfi Guindo sold 10,000 shares for $1.35M on Aug 13.
  • Total cluster value of $7.29M represents ~0.002% of Merck's $327.9B market cap.
  • Sales occurred 6-9 days after Merck's Q2 earnings beat (Aug 4), a typical post-blackout window.
  • Merck raised FY2026 sales guidance to $66.3B-$67.3B but lowered EPS guidance due to acquisition charges.

Financial Impact

Total insider sales of $7.29M are immaterial relative to $327.9B market cap (0.002%).

Risk Factors

  • Insider sales at mega-caps are almost always liquidity-driven; no material risk signaled here.
  • If additional C-suite sales emerge in the next 30 days, the pattern would warrant closer scrutiny.

Market Snapshot

Price
$134.55
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MRK-1786654971985
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.28 (−0.45%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.28 (−2.88%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.28 (−4.19%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.28 (+4.90%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.28 (−3.83%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.28 (+5.48%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.28 (+5.70%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.28 (+5.70%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.28 (+7.79%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.28 (+7.79%)
Showing 10 of 20

US Market Status

Market Open — Closes in 4h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 13, 2026